Frontlight ResearchEarly access
Trial site
Research Institute Of Dallas
- 3running trials
- 6closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes5 trials
- Type 1 diabetes4 trials
- Chronic kidney disease2 trials
- Obesity2 trials
- Graves' disease1 trial
- Phase
- Phase 38 trials
- Phase 21 trial
- Status
- Completed6 trials
- Recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Eli Lilly and Company4 trials
- Novo Nordisk A/S2 trials
- argenx1 trial
- Boehringer Ingelheim1 trial
- Carmot Therapeutics, Inc.1 trial
Running trials
Recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Graves' disease1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
Completed
Completed
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
Site data: ClinicalTrials.govUpdated 14 Nov 2026